SymbolBNGO
NameBIONANO GENOMICS, INC.
SectorINDUSTRIALS
RegionNorth America
IndustryBiotechnology: Laboratory Analytical Instruments
Address9540 TOWNE CENTRE DRIVE,SUITE 100, SAN DIEGO, California, 92121, United States
Telephone+1 858 888-7600
Fax
Email
Websitehttps://www.bionano.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK
Description

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Additional info from NASDAQ:
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

2026-04-02 17:07

New Form ARS - Bionano Genomics, Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001411690-26-000016 <b>Size:</b> 1 MB

Read more
2026-04-02 17:05

New Form DEFA14A - Bionano Genomics, Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001411690-26-000015 <b>Size:</b> 1 MB

Read more
2026-04-02 17:03

New Form DEF 14A - Bionano Genomics, Inc. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001411690-26-000014 <b>Size:</b> 8 MB

Read more
2026-03-25 17:29

New Form S-8 - Bionano Genomics, Inc. <b>Filed:</b> 2026-03-25 <b>AccNo:</b> 0001411690-26-000011 <b>Size:</b> 301 KB

Read more
2026-03-23 20:05

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Read more
2026-03-23 20:04

(30% Negative) BIONANO GENOMICS, INC. (BNGO) Reports Q1 2026 Financial Results

Read more
2026-03-09 20:05

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

Read more
2026-02-27 13:00

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

Read more
2026-02-26 13:00

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

Read more
2026-02-24 13:00

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

Read more